Application of plasma metabolome for monitoring the effect of rivaroxaban in patients with nonvalvular atrial fibrillation

Rivaroxaban, an oral factor Xa inhibitor, has been used to treating a series of thromboembolic disorders in clinical practice. Measurement of the anticoagulant effect of rivaroxaban is important to avoid serious bleeding events, thus ensuring the safety and efficacy of drug administration. Metabolom...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Mindi, Liu, Xiaoyan, Bu, Xiaoxiao, Li, Yao, Wang, Meng, Zhang, Bo, Sun, Wei, Li, Chuanbao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2022
Materias:
Molecular Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373988/
https://www.ncbi.nlm.nih.gov/pubmed/35966924
http://dx.doi.org/10.7717/peerj.13853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373988/
https://www.ncbi.nlm.nih.gov/pubmed/35966924
http://dx.doi.org/10.7717/peerj.13853

Ejemplares similares